— Know what they know.
Not Investment Advice

002287.SZ SHZ

Tibet Cheezheng Tibetan Medicine Co., Ltd.
1W: -1.7% 1M: -3.8% 3M: -1.6% YTD: -22.1% 1Y: -32.9% 3Y: -11.1% 5Y: -20.1%
¥19.38 ($2.89)
+0.26 (+1.36%)
 
SHZ · Healthcare · Biotechnology · Tech Score Sell · Power 38 · ¥11.1B mcap · 66M float · 3.46% daily turnover

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A
Sep 30, 2026
DCF
5
ROE
4
ROA
5
D/E
3
P/E
2
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. 002287.SZ receives an overall rating of A. Strongest factors: DCF (5/5), ROE (4/5), ROA (5/5). Areas of concern: P/E (2/5).
Rating Change History
DateFromTo
2026-09-14 A- A
2026-08-10 A A-
2026-07-27 A- A
2026-05-06 None ADDED
2026-05-05 EXISTED None
2026-04-27 C A-
2026-02-24 None ADDED
2026-02-18 EXISTED None

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 55 Grade A
Profitability
81
Balance Sheet
97
Earnings Quality
58
Growth
35
Value
68
Momentum
53
Safety
100
Cash Flow
41
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. 002287.SZ scores highest in Safety (100/100) and lowest in Growth (35/100). An overall grade of A places 002287.SZ among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
5.72
Safe Zone
Piotroski F-Score
5/9
✓ ✓ ✓ ✗ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
-2.32
Unlikely Manipulator
Ohlson O-Score
-10.50
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AAA
Score: 96.1/100
Trend: Improving
Earnings Quality
50/100
OCF/NI: 0.79x
Accruals: 2.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. 002287.SZ scores 5.72, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. 002287.SZ scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. 002287.SZ's score of -2.32 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. 002287.SZ's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. 002287.SZ receives an estimated rating of AAA (score: 96.1/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). 002287.SZ's score of 50/100 is moderate — some divergence between reported earnings and underlying cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
16.56x
PEG
19.21x
P/S
5.00x
P/B
2.16x
P/FCF
29.57x
P/OCF
20.53x
EV/EBITDA
11.63x
EV/Revenue
3.91x
EV/EBIT
13.09x
EV/FCF
24.01x
Earnings Yield
6.17%
FCF Yield
3.38%
Shareholder Yield
0.07%
Graham Number
$15.34
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 16.6x earnings, 002287.SZ trades at a reasonable valuation. An earnings yield of 6.2% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $15.34 per share, 26% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.883
NI / EBT
×
Interest Burden
1.126
EBT / EBIT
×
EBIT Margin
0.299
EBIT / Rev
×
Asset Turnover
0.327
Rev / Assets
×
Equity Multiplier
1.484
Assets / Equity
=
ROE
14.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. 002287.SZ's ROE of 14.4% is driven by Asset Turnover (0.327), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
3.75%
Fair P/E
15.99x
Intrinsic Value
$18.59
Price/Value
1.01x
Margin of Safety
-1.32%
Premium
1.32%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with 002287.SZ's realized 3.7% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. 002287.SZ trades at a 1% premium to its adjusted intrinsic value of $18.59, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 16.0x compares to the current market P/E of 16.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$19.38
Median 1Y
$18.14
5th Pctile
$9.99
95th Pctile
$33.04
Ann. Volatility
36.4%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 25.6% 24.7% 23.4% -1.2% 13.6% 14.5% 14.3% 16.9% 14.7% 16.5% 16.2% 16.4% 16.1% 15.0% 14.3% 15.7% 14.1% 14.3% 14.7% 14.4% 14.43%
ROA 15.5% 14.3% 14.1% -0.7% 8.1% 8.2% 8.3% 9.1% 8.3% 9.5% 9.2% 9.0% 9.2% 8.9% 8.3% 9.1% 9.3% 9.4% 10.0% 9.7% 9.72%
ROIC 29.6% 25.7% 23.8% -1.5% 14.2% 16.7% 15.5% 20.3% 14.7% 20.2% 18.1% 22.9% 26.2% 22.1% 22.7% 26.0% 22.1% 23.0% 21.4% 20.0% 20.01%
ROCE 9.4% 10.7% 11.2% 11.6% 12.8% 11.7% 9.0% 9.6% 8.4% 9.3% 9.8% 10.4% 10.8% 11.5% 11.7% 11.9% 11.0% 12.6% 12.7% 12.3% 12.26%
Gross Margin 84.0% 83.6% 85.3% 83.7% 86.4% 81.6% 80.7% 86.3% 84.4% 83.8% 81.4% 82.1% 81.0% 82.8% 81.5% 82.6% 82.3% 1.3% 83.9% 78.8% 78.83%
Operating Margin -92.3% 13.3% 22.2% 32.8% 26.7% 21.0% 33.6% 45.2% 17.9% 29.0% 31.0% 39.3% 18.2% 23.8% 24.5% 41.5% 20.8% 30.4% 26.9% 43.5% 43.50%
Net Margin -83.7% 11.8% 21.4% 29.7% 24.5% 18.0% 31.3% 41.1% 16.4% 25.1% 26.7% 35.4% 14.7% 21.8% 18.8% 36.6% 18.7% 24.9% 23.5% 48.2% 48.21%
EBITDA Margin 23.8% 13.3% 40.0% 44.5% 32.2% 7.6% 22.7% 46.2% 29.6% 13.8% 29.2% 44.2% 32.6% 17.2% 30.1% 38.9% 30.6% 27.0% 27.4% 50.0% 49.98%
FCF Margin 18.9% 52.1% 40.4% 24.8% 29.9% 9.2% 16.3% 27.1% 15.6% 48.1% 32.1% 18.2% 24.0% 0.9% 19.6% 23.5% 24.8% 24.8% 8.6% 16.3% 16.28%
OCF Margin 34.0% 59.1% 50.2% 37.3% 41.9% 22.5% 28.1% 36.5% 25.9% 59.6% 44.2% 34.5% 38.6% 2.2% 20.9% 19.6% 22.0% 31.2% 13.8% 23.4% 23.45%
ROE 3Y Avg snapshot only 14.61%
ROE 5Y Avg snapshot only 11.72%
ROA 3Y Avg snapshot only 9.21%
ROIC 3Y Avg snapshot only 21.13%
ROIC Economic snapshot only 10.32%
Cash ROA snapshot only 7.73%
Cash ROIC snapshot only 16.85%
CROIC snapshot only 11.69%
NOPAT Margin snapshot only 27.85%
Pretax Margin snapshot only 33.62%
R&D / Revenue snapshot only 4.12%
SGA / Revenue snapshot only 67.24%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 22.35 20.43 19.73 -304.79 24.44 23.69 25.87 21.24 26.31 19.31 18.53 16.43 19.78 18.82 21.00 18.83 23.32 20.81 19.55 16.20 16.564
P/S Ratio 9.80 8.23 7.44 6.53 5.24 5.48 6.40 5.93 6.93 5.49 5.13 4.39 5.17 4.69 4.95 4.63 5.98 5.57 5.38 4.81 4.997
P/B Ratio 5.25 4.61 4.24 3.99 3.25 3.36 3.61 3.41 3.70 3.02 2.84 2.58 3.04 2.70 2.93 2.87 2.97 2.72 2.58 2.09 2.155
P/FCF 51.82 15.81 18.43 26.38 17.52 59.74 39.31 21.87 44.29 11.41 15.98 24.14 21.53 538.14 25.23 19.65 24.12 22.41 62.36 29.57 29.573
P/OCF 28.79 13.92 14.83 17.52 12.51 24.35 22.77 16.28 26.79 9.21 11.62 12.72 13.39 217.98 23.66 23.58 27.15 17.86 39.00 20.53 20.529
EV/EBITDA 35.20 28.30 24.87 21.03 16.34 17.92 24.01 20.81 26.47 18.98 17.52 13.75 15.62 13.85 14.58 13.86 18.20 14.84 14.70 11.63 11.631
EV/Revenue 9.43 8.01 7.26 6.19 5.12 5.23 6.21 5.57 6.84 5.07 4.86 3.86 4.49 4.10 4.33 3.99 5.16 4.73 4.62 3.91 3.908
EV/EBIT 39.06 31.29 27.53 23.58 18.21 20.25 28.08 24.15 31.47 22.20 20.35 16.18 18.30 16.22 17.17 16.35 21.96 17.26 16.46 13.09 13.089
EV/FCF 49.85 15.38 17.98 25.03 17.11 57.01 38.18 20.51 43.78 10.55 15.12 21.22 18.67 470.16 22.06 16.96 20.82 19.04 53.48 24.01 24.009
Earnings Yield 4.5% 4.9% 5.1% -0.3% 4.1% 4.2% 3.9% 4.7% 3.8% 5.2% 5.4% 6.1% 5.1% 5.3% 4.8% 5.3% 4.3% 4.8% 5.1% 6.2% 6.17%
FCF Yield 1.9% 6.3% 5.4% 3.8% 5.7% 1.7% 2.5% 4.6% 2.3% 8.8% 6.3% 4.1% 4.6% 0.2% 4.0% 5.1% 4.1% 4.5% 1.6% 3.4% 3.38%
PEG Ratio snapshot only 19.214
Price/Tangible Book snapshot only 2.221
EV/OCF snapshot only 16.666
EV/Gross Profit snapshot only 3.868
Acquirers Multiple snapshot only 12.354
Shareholder Yield snapshot only 0.07%
Graham Number snapshot only $15.34
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 3.80 2.24 2.73 2.28 2.68 2.35 2.58 2.21 2.20 2.57 2.28 2.49 3.16 2.50 2.57 2.53 2.63 2.57 3.12 2.99 2.985
Quick Ratio 3.66 2.15 2.62 2.28 2.56 2.25 2.46 2.13 2.09 2.44 2.18 2.39 3.02 2.38 2.43 2.41 2.45 2.39 2.86 2.74 2.738
Debt/Equity 0.41 0.46 0.45 0.48 0.45 0.51 0.53 0.60 0.60 0.41 0.52 0.49 0.46 0.40 0.43 0.40 0.22 0.19 0.16 0.18 0.183
Net Debt/Equity -0.20 -0.13 -0.10 -0.20 -0.07 -0.15 -0.10 -0.21 -0.04 -0.23 -0.15 -0.31 -0.41 -0.34 -0.37 -0.39 -0.41 -0.41 -0.37 -0.39 -0.394
Debt/Assets 0.25 0.26 0.27 0.26 0.27 0.29 0.30 0.32 0.33 0.24 0.29 0.28 0.27 0.24 0.26 0.24 0.16 0.13 0.12 0.14 0.139
Debt/EBITDA 2.83 2.89 2.71 2.68 2.33 2.84 3.62 3.92 4.37 2.78 3.39 2.97 2.74 2.33 2.44 2.25 1.58 1.20 1.05 1.25 1.251
Net Debt/EBITDA -1.39 -0.79 -0.62 -1.14 -0.38 -0.86 -0.71 -1.38 -0.31 -1.55 -0.99 -1.89 -2.40 -2.00 -2.09 -2.20 -2.88 -2.63 -2.44 -2.70 -2.696
Interest Coverage 6.87 7.88 8.28 8.02 10.00 9.35 7.43 7.22 6.93 7.41 7.97 9.20 8.89 10.21 10.57 10.75 10.85 15.81 23.36 40.02 40.022
Equity Multiplier 1.65 1.76 1.68 1.82 1.70 1.77 1.75 1.89 1.82 1.69 1.77 1.78 1.69 1.67 1.67 1.69 1.38 1.40 1.32 1.32 1.320
Cash Ratio snapshot only 2.217
Debt Service Coverage snapshot only 45.040
Cash to Debt snapshot only 3.154
FCF to Debt snapshot only 0.387
Defensive Interval snapshot only 1312.7 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.35 0.35 0.38 0.34 0.38 0.36 0.34 0.33 0.32 0.34 0.33 0.34 0.35 0.36 0.35 0.37 0.36 0.35 0.36 0.33 0.327
Inventory Turnover 2.70 2.57 2.62 7.62 2.46 2.64 2.30 4.11 2.06 2.29 2.07 2.36 2.33 2.46 2.19 2.39 1.82 0.00 -0.03 -0.08 -0.084
Receivables Turnover 3.42 96.07 5.29 7.90 8.11 4.78 5.04 7.13 7.38 4.54 10.17 7.28 10.07 27.46 11.01 6.15 5.29 24.90 11.20 3.95 3.955
Payables Turnover 8.65 2.32 2.42 3.05 3.71 2.35 2.62 2.48 2.52 1.81 2.02 2.59 2.75 1.67 1.77 2.25 2.54 0.00 -0.05 -0.14 —
DSO 107 4 69 46 45 76 72 51 49 80 36 50 36 13 33 59 69 15 33 92 92.3 days
DIO 135 142 140 48 148 138 159 89 177 160 176 154 157 149 166 152 201 — — — —
DPO 42 157 151 120 98 156 139 147 145 202 181 141 133 218 206 162 144 — — — —
Cash Conversion Cycle 200 -12 58 -25 95 59 92 -7 81 38 31 64 60 -56 -6 49 126 — — — —
Fixed Asset Turnover snapshot only 1.292
Operating Cycle snapshot only 280.6 days
Cash Velocity snapshot only 0.754
Capital Intensity snapshot only 3.033
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 14.0% 19.5% 11.6% 13.7% 20.5% 15.2% 4.3% 4.9% -6.1% 0.0% 9.4% 12.5% 21.1% 14.3% 12.4% 12.5% 5.2% 3.3% 1.8% -11.4% -11.36%
Net Income 76.0% 77.1% 52.5% -1.0% -41.1% -33.9% -31.6% 14.7% 15.3% 23.0% 22.5% 7.6% 20.4% 0.2% -4.3% 3.4% 3.1% 11.0% 18.8% 7.2% 7.18%
EPS 75.6% 76.6% 53.3% -1.0% -41.1% -34.0% -31.7% 14.6% 15.2% 22.8% 22.4% 7.7% 20.3% 0.1% -4.5% 3.2% 0.3% 3.6% 11.4% 0.4% 0.41%
FCF 46.7% 10.1% 5.2% 1.4% 90.5% -79.7% -58.0% 15.0% -50.9% 4.2% 1.2% -24.6% 86.1% -97.9% -31.4% 45.6% 8.5% 28.5% -55.2% -38.7% -38.73%
EBITDA 5.5% 28.1% 18.4% 19.6% 40.9% 18.7% -7.5% -4.8% -22.5% -8.3% 17.2% 18.1% 34.5% 26.4% 20.4% 15.5% 3.9% 11.3% 7.6% 3.3% 3.33%
Op. Income 66.7% 73.4% 50.1% -1.0% -40.9% -34.0% -30.7% 13.7% 17.0% 23.9% 24.5% 10.1% 24.8% 1.6% -2.7% 5.6% 2.4% 16.1% 20.4% -1.1% -1.13%
OCF Growth snapshot only 5.91%
Asset Growth snapshot only -1.46%
Equity Growth snapshot only 26.30%
Debt Growth snapshot only -42.55%
Shares Change snapshot only 6.74%
Dividend Growth snapshot only -98.24%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 10.8% 13.5% 14.4% 13.8% 14.6% 13.4% 14.1% 12.1% 8.8% 11.3% 8.4% 10.3% 11.1% 9.6% 8.6% 9.9% 6.2% 5.7% 7.7% 3.9% 3.91%
Revenue 5Y 10.9% 12.9% 13.8% 13.8% 14.4% 14.2% 12.2% 11.7% 9.0% 11.0% 11.3% 11.7% 11.3% 10.8% 12.8% 12.2% 10.4% 10.2% 7.8% 6.0% 5.98%
EPS 3Y 28.9% 30.8% 28.7% — 6.9% 8.9% 13.2% 12.7% 6.0% 12.7% 8.6% -20.1% -6.6% -6.7% -7.2% — 11.6% 8.4% 9.2% 3.7% 3.75%
EPS 5Y 21.0% 19.7% 18.8% — 7.5% 9.4% 9.0% 11.3% 7.7% 12.6% 12.3% 12.3% 11.1% 9.7% 11.1% 9.8% 7.5% 8.2% 6.4% -12.0% -11.98%
Net Income 3Y 29.0% 30.9% 28.9% — 7.1% 9.1% 13.4% 13.0% 6.1% 12.9% 8.5% -20.2% -6.5% -6.6% -7.1% — 12.7% 11.0% 11.7% 6.1% 6.06%
Net Income 5Y 21.1% 19.8% 18.9% — 7.6% 9.5% 9.2% 11.4% 7.8% 12.8% 12.4% 12.4% 11.3% 9.8% 11.3% 9.9% 8.2% 9.9% 7.7% -10.9% -10.86%
EBITDA 3Y 7.6% 13.4% 16.1% 16.2% 19.5% 19.7% 17.0% 11.5% 4.8% 11.7% 8.7% 10.4% 13.7% 11.2% 9.3% 9.1% 2.7% 8.9% 14.9% 12.1% 12.12%
EBITDA 5Y 9.0% 12.4% 13.9% 14.4% 16.4% 13.2% 8.7% 9.1% 6.3% 9.7% 11.2% 12.0% 12.2% 14.7% 17.7% 13.6% 10.0% 14.4% 10.7% 9.9% 9.93%
Gross Profit 3Y 9.4% 12.2% 13.0% 12.3% 13.5% 12.2% 12.7% 11.1% 7.8% 10.7% 7.8% 9.4% 10.1% 8.5% 7.5% 9.1% 5.2% 12.0% 14.7% 10.5% 10.49%
Gross Profit 5Y 11.6% 12.9% 13.7% 13.5% 13.9% 13.3% 11.1% 10.8% 7.9% 10.1% 10.4% 10.5% 10.1% 9.5% 11.6% 11.2% 9.6% 13.8% 11.3% 9.7% 9.68%
Op. Income 3Y 28.4% 30.7% 28.0% — 6.9% 9.1% 13.3% 11.7% 4.8% 12.4% 9.0% -19.4% -4.8% -6.0% -5.7% — 14.3% 13.5% 13.4% 4.7% 4.74%
Op. Income 5Y 23.7% 23.5% 22.3% — 9.7% 10.1% 9.9% 11.6% 7.9% 12.8% 12.6% 12.9% 12.3% 10.4% 12.0% 10.1% 8.0% 10.9% 8.7% -11.4% -11.36%
FCF 3Y 4.0% 35.6% 55.6% 25.8% 30.3% -19.1% -20.8% 8.3% 11.1% — — 27.1% 20.3% -72.0% -14.6% 8.1% -0.3% 47.4% -12.8% -12.4% -12.37%
FCF 5Y 13.5% 34.6% 28.3% 3.9% 18.0% 2.7% 7.7% 19.5% 1.0% 21.6% 27.9% 11.5% 15.1% -43.5% -6.0% 6.9% 22.6% — — 12.9% 12.87%
OCF 3Y 14.6% 28.1% 43.4% 27.2% 32.7% 4.2% -12.2% 6.0% 6.8% 72.4% 1.7% 21.6% 15.9% -63.7% -18.8% -11.2% -14.3% 17.9% -15.0% -10.3% -10.31%
OCF 5Y 13.9% 22.0% 19.6% 5.7% 16.0% 14.9% 12.9% 18.8% 5.3% 19.5% 24.3% 17.6% 19.7% -34.1% -9.1% -4.1% 5.7% 25.9% 47.4% 4.0% 4.04%
Assets 3Y 30.3% 34.0% 32.7% 30.7% 25.5% 25.4% 25.8% 21.9% 14.2% 12.2% 15.4% 6.4% 8.6% 6.8% 7.0% 6.7% 6.7% 5.5% 3.6% 1.2% 1.18%
Assets 5Y 20.3% 21.8% 21.0% 20.1% 20.1% 20.7% 19.7% 20.7% 22.7% 22.2% 23.6% 21.7% 18.8% 17.9% 17.4% 13.7% 9.1% 9.2% 8.6% 3.7% 3.74%
Equity 3Y 16.5% 16.0% 15.5% 14.2% 14.3% 14.1% 14.3% 14.4% 10.7% 12.4% 11.9% 3.4% 7.7% 8.6% 7.3% 9.4% 14.3% 14.0% 13.7% 14.0% 13.97%
Book Value 3Y 16.4% 15.9% 15.3% 14.0% 14.2% 13.9% 14.1% 14.2% 10.5% 12.3% 12.0% 3.5% 7.6% 8.5% 7.2% 9.3% 13.2% 11.4% 11.2% 11.5% 11.49%
Dividend 3Y 0.0% 0.0% 1.4% 2.5% 20.8% 20.1% 17.0% 15.7% -14.4% 7.3% 8.5% 8.7% 30.9% -12.6% -2.0% -2.3% -37.2% -25.9% -71.3% -74.0% -74.00%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.98 0.97 0.94 0.98 0.96 0.97 0.95 0.98 0.89 0.95 0.98 0.99 0.90 0.97 0.98 0.99 0.91 0.95 0.97 0.75 0.746
Earnings Stability 0.70 0.68 0.71 0.01 0.42 0.53 0.56 0.01 0.25 0.49 0.53 0.01 0.20 0.32 0.31 0.00 0.09 0.19 0.16 0.01 0.006
Margin Stability 0.97 0.98 0.99 0.99 0.99 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.98 0.92 0.91 0.91 0.910
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.000
Earn. Growth Consistency 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.000
FCF Positive Streak 1 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.20 0.84 0.86 0.87 0.20 0.94 0.91 0.91 0.50 0.92 1.00 0.98 0.99 0.99 0.96 0.92 0.97 0.971
Earnings Smoothness 0.45 0.44 0.58 — 0.48 0.59 0.62 — 0.86 0.79 0.80 0.93 0.82 1.00 0.96 0.97 0.97 0.90 0.83 0.93 0.931
ROE Trend 0.07 0.07 0.06 -0.27 -0.06 -0.05 -0.05 -0.00 -0.04 -0.03 -0.02 0.08 0.02 -0.01 -0.01 -0.01 -0.02 -0.02 -0.01 -0.03 -0.025
Gross Margin Trend -0.02 -0.02 -0.01 -0.02 -0.01 -0.01 -0.02 -0.01 -0.01 -0.00 0.00 -0.01 -0.02 -0.02 -0.02 -0.01 -0.00 0.17 0.17 0.18 0.184
FCF Margin Trend 0.01 0.43 0.21 0.04 0.13 -0.13 0.01 0.09 -0.09 0.17 0.04 -0.08 0.01 -0.28 -0.05 0.01 0.05 0.00 -0.17 -0.05 -0.046
Sustainable Growth Rate 18.7% 18.0% 16.5% — 2.7% 4.1% 4.4% 6.8% 8.2% 4.5% 4.5% 4.8% 2.9% 7.7% 4.1% 5.6% 11.3% 11.6% 14.5% 14.3% 14.27%
Internal Growth Rate 12.8% 11.6% 11.1% — 1.6% 2.4% 2.6% 3.8% 4.9% 2.7% 2.6% 2.7% 1.7% 4.8% 2.5% 3.4% 8.0% 8.3% 10.9% 10.6% 10.64%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.78 1.47 1.33 -17.39 1.95 0.97 1.14 1.31 0.98 2.10 1.59 1.29 1.48 0.09 0.89 0.80 0.86 1.17 0.50 0.79 0.789
FCF/OCF 0.56 0.88 0.80 0.66 0.71 0.41 0.58 0.74 0.60 0.81 0.73 0.53 0.62 0.41 0.94 1.20 1.13 0.80 0.63 0.69 0.694
FCF/Net Income snapshot only 0.548
OCF/EBITDA snapshot only 0.698
CapEx/Revenue 15.1% 7.1% 9.8% 12.5% 12.0% 13.3% 11.8% 9.3% 10.2% 11.5% 12.1% 16.3% 14.6% 10.9% 10.8% 5.1% 6.7% 6.3% 5.2% 7.2% 7.17%
CapEx/Depreciation snapshot only 1.916
Accruals Ratio 0.03 -0.07 -0.05 -0.13 -0.08 0.00 -0.01 -0.03 0.00 -0.10 -0.05 -0.03 -0.04 0.08 0.01 0.02 0.01 -0.02 0.05 0.02 0.020
Sloan Accruals snapshot only -0.003
Cash Flow Adequacy snapshot only 3.124
Earnings Quality Score snapshot only 0.500
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 1.2% 1.3% 1.5% 1.7% 3.3% 3.0% 2.7% 2.8% 1.7% 3.8% 3.9% 4.3% 4.1% 2.6% 3.4% 3.4% 0.9% 0.9% 0.1% 0.1% 1.19%
Dividend/Share $0.37 $0.37 $0.39 $0.40 $0.65 $0.64 $0.63 $0.62 $0.41 $0.80 $0.80 $0.80 $0.92 $0.53 $0.75 $0.74 $0.23 $0.22 $0.02 $0.01 $0.23
Payout Ratio 26.7% 27.3% 29.4% — 80.3% 72.1% 69.3% 59.7% 43.8% 72.6% 72.0% 70.9% 81.9% 48.5% 71.0% 64.2% 20.3% 19.1% 1.5% 1.1% 1.12%
FCF Payout Ratio 62.0% 21.2% 27.5% 45.3% 57.6% 1.8% 1.1% 61.4% 73.8% 42.9% 62.1% 1.0% 89.1% 13.9% 85.3% 67.0% 21.0% 20.6% 4.8% 2.1% 2.05%
Total Payout Ratio 26.7% 27.3% 29.4% — 80.5% 72.3% 69.5% 59.7% 43.9% 72.7% 72.1% 70.9% 81.9% 48.5% 71.0% 73.8% 29.9% 28.2% 10.4% 1.1% 1.12%
Div. Increase Streak 1 1 1 1 1 1 1 1 0 1 1 1 0 0 0 0 0 0 0 0 0
Chowder Number 0.02 0.02 0.06 0.10 0.80 0.77 0.64 0.59 -0.35 0.28 0.31 0.32 1.29 -0.31 -0.02 -0.03 -0.74 -0.55 -0.97 -0.98 -0.981
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.5% 0.4% 0.4% 0.5% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -2.1% -1.9% -2.2% -2.3% 0.0% 0.0% 0.0% 0.0% 0.5% 0.4% 0.4% 0.5% 0.0% 0.00%
Total Shareholder Return 1.2% 1.3% 1.5% 1.7% 3.3% 3.1% 2.7% 0.7% -0.3% 1.5% 1.6% 4.3% 4.1% 2.6% 3.4% 3.9% 1.3% 1.4% 0.5% 0.1% 0.07%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.93 0.91 0.92 0.82 0.92 0.91 0.91 0.91 0.91 0.90 0.89 0.89 0.88 0.90 0.90 0.90 0.90 0.88 0.88 0.88 0.883
Interest Burden (EBT/EBIT) 1.96 1.73 1.56 -0.10 0.83 0.98 1.23 1.33 1.33 1.38 1.30 1.26 1.21 1.09 1.04 1.12 1.21 1.11 1.11 1.13 1.126
EBIT Margin 0.24 0.26 0.26 0.26 0.28 0.26 0.22 0.23 0.22 0.23 0.24 0.24 0.25 0.25 0.25 0.24 0.23 0.27 0.28 0.30 0.299
Asset Turnover 0.35 0.35 0.38 0.34 0.38 0.36 0.34 0.33 0.32 0.34 0.33 0.34 0.35 0.36 0.35 0.37 0.36 0.35 0.36 0.33 0.327
Equity Multiplier 1.65 1.73 1.65 1.72 1.67 1.76 1.72 1.86 1.76 1.73 1.76 1.83 1.75 1.68 1.72 1.73 1.52 1.52 1.48 1.48 1.484
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $1.37 $1.35 $1.32 $-0.08 $0.81 $0.89 $0.90 $1.04 $0.93 $1.10 $1.10 $1.12 $1.12 $1.10 $1.06 $1.16 $1.12 $1.14 $1.18 $1.16 $1.16
Book Value/Share $5.85 $5.99 $6.15 $5.83 $6.07 $6.30 $6.47 $6.49 $6.63 $7.02 $7.20 $7.15 $7.28 $7.66 $7.57 $7.60 $8.81 $8.71 $8.90 $8.99 $9.08
Tangible Book/Share $5.35 $5.23 $5.41 $5.10 $5.36 $5.59 $5.78 $5.81 $5.96 $6.35 $6.55 $6.51 $6.66 $7.05 $6.97 $7.01 $8.25 $8.17 $8.38 $8.48 $8.48
Revenue/Share $3.13 $3.35 $3.50 $3.56 $3.77 $3.86 $3.65 $3.73 $3.54 $3.86 $3.99 $4.20 $4.28 $4.41 $4.47 $4.71 $4.38 $4.25 $4.27 $3.91 $3.91
FCF/Share $0.59 $1.75 $1.41 $0.88 $1.13 $0.35 $0.59 $1.01 $0.55 $1.86 $1.28 $0.76 $1.03 $0.04 $0.88 $1.11 $1.09 $1.06 $0.37 $0.64 $0.64
OCF/Share $1.07 $1.98 $1.76 $1.33 $1.58 $0.87 $1.03 $1.36 $0.91 $2.30 $1.76 $1.45 $1.65 $0.09 $0.94 $0.92 $0.97 $1.33 $0.59 $0.92 $0.92
Cash/Share $3.54 $3.50 $3.40 $4.00 $3.21 $4.16 $4.09 $5.28 $4.29 $4.46 $4.84 $5.73 $6.32 $5.65 $6.02 $6.04 $5.55 $5.19 $4.69 $5.19 $5.19
EBITDA/Share $0.84 $0.95 $1.02 $1.05 $1.18 $1.13 $0.94 $1.00 $0.92 $1.03 $1.11 $1.18 $1.23 $1.30 $1.33 $1.36 $1.24 $1.35 $1.34 $1.32 $1.32
Debt/Share $2.38 $2.74 $2.77 $2.81 $2.76 $3.19 $3.42 $3.91 $4.00 $2.87 $3.75 $3.50 $3.37 $3.04 $3.24 $3.06 $1.96 $1.62 $1.41 $1.65 $1.65
Net Debt/Share $-1.16 $-0.75 $-0.63 $-1.19 $-0.45 $-0.97 $-0.67 $-1.37 $-0.29 $-1.60 $-1.09 $-2.23 $-2.95 $-2.61 $-2.78 $-2.98 $-3.58 $-3.56 $-3.27 $-3.54 $-3.54
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 5.723
Altman Z-Prime snapshot only 11.598
Piotroski F-Score 5 6 5 4 5 4 3 5 3 7 7 8 7 4 6 7 6 8 7 5 5
Beneish M-Score -2.06 -2.56 -2.66 -3.99 -2.76 -2.53 -1.96 -2.55 -2.37 -3.12 -2.73 -3.13 -2.99 -1.78 -2.79 -1.64 -2.29 -2.90 -1.92 -2.32 -2.316
Ohlson O-Score snapshot only -10.496
ROIC (Greenblatt) snapshot only 15.22%
Net-Net WC snapshot only $4.20
EVA snapshot only $309114365.88
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only AAA
Credit Score 84.25 87.22 87.58 87.61 90.84 84.51 84.03 81.77 79.78 88.30 83.04 84.72 88.69 84.81 89.10 89.82 90.86 93.36 95.36 96.14 96.144
Credit Grade snapshot only 1
Credit Trend snapshot only 6.328
Implied Spread (bps) snapshot only 50.000
Industry Credit Rank snapshot only 96
Sector Credit Rank snapshot only 92

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms